Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Intellia Therapeutics Inc (NASDAQ: NTLA) closed at $9.46 in the last session, down -8.60% from day before closing price of $10.35. In other words, the price has decreased by -$8.60 from its previous closing price. On the day, 3.66 million shares were traded.
Ratios:
We take a closer look at NTLA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.77 and its Current Ratio is at 5.77. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.22.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on March 05, 2025, initiated with a Buy rating and assigned the stock a target price of $30.
On February 28, 2025, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $45 to $13.
Goldman Downgraded its Neutral to Sell on February 28, 2025, while the target price for the stock was maintained at $9.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 04 ’25 when Clark Eliana sold 679 shares for $8.99 per share. The transaction valued at 6,104 led to the insider holds 95,369 shares of the business.
BASTA JAMES sold 2,572 shares of NTLA for $23,122 on Mar 04 ’25. The EVP, General Counsel now owns 111,925 shares after completing the transaction at $8.99 per share. On Jan 29 ’25, another insider, Bhanji Muna, who serves as the Director of the company, sold 265 shares for $9.97 each. As a result, the insider received 2,642 and left with 19,468 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 16.92 while its Price-to-Book (P/B) ratio in mrq is 1.11.
Stock Price History:
Over the past 52 weeks, NTLA has reached a high of $32.00, while it has fallen to a 52-week low of $8.30. The 50-Day Moving Average of the stock is -11.13%, while the 200-Day Moving Average is calculated to be -47.33%.
Shares Statistics:
A total of 102.03M shares are outstanding, with a floating share count of 97.42M. Insiders hold about 5.89% of the company’s shares, while institutions hold 90.18% stake in the company.
